• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    More On RDHL

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    RedHill Biopharma Ltd. (RDHL)

    -NasdaqCM
    14.70 0.00(0.00%) Apr 24, 3:59PM EDT
    Add to Portfolio
    Prev Close:14.70
    Open:N/A
    Bid:14.63 x 200
    Ask:N/A
    1y Target Est:26.83
    Beta:-0.42
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:6.89 - 21.00
    Volume:0
    Avg Vol (3m):30,716
    Market Cap:146.09M
    P/E (ttm):N/A
    EPS (ttm):-1.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RDHL

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):20.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.56
    Quarterly EPS Est (Mar-15) :-0.47
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RedHill Biopharma Ltd., a biopharmaceutical company, focuses on the development and acquisition of late clinical-stage, proprietary, and orally-administered drugs for the treatment of inflammatory and gastrointestinal diseases, including gastroint... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback